While studies on death receptors have long been restricted to immune cells, the last decade has provided a strong body of evidence for their implication in neuronal death and hence neurodegenerative disorders such as amyotrophic lateral sclerosis (ALS). ALS is a fatal paralytic disorder that primarily affects motoneurons in the brain and spinal cord. A neuroinflammatory process, associated with astrocyte and microglial activation as well as infiltration of immune cells, accompanies motoneuron degeneration and supports the contribution of non-cell-autonomous mechanisms in the disease. Hallmarks of Fas, TNFR, LT- β R, and p7 5 N T R signaling have been observed in both animal models and ALS patients. This review summarizes to date knowledge of the role of death receptors in ALS and the link existing between the selective loss of motoneurons and neuroinflammation. It further suggests how this recent evidence could be included in an ultimate multiapproach to treat patients.
Aebischer, J., Bernard-Marissal, N., Pettmann, B., & Raoul, C. (2013). Death Receptors in the Selective Degeneration of Motoneurons in Amyotrophic Lateral Sclerosis. Journal of Neurodegenerative Diseases, 2013, 1–11. https://doi.org/10.1155/2013/746845